CureVac up 13% as court upholds validity of patent in BioNTech spat Posted on March 27, 2025 by wpadmin Matthias Hangst/Getty Images News CureVac (NASDAQ:CVAC) is up ~13% in after-hours trading Thursday after the European Patent Court deemed valid a key patent that the biotech says is central to its technology amid a challenge from German rival BioNTech (NASDAQ:BNTX). The patent in question, EP
